Breaking news.
On January 15, 2025, the official announcement and handover of the European Vitiligo White Paper took place in the European Parliament (legislative body of the European Union) in Brussels.
See the link for the full text https://www.vipoc.org/european-vitiligo-white-paper/
This so-called white paper is the very first (and therefore unique) International policy document on vitiligo and not only describes the (unmet) needs of people with vitiligo but also provides recommendations for better care and treatments. It was created through a joint effort of a Scientific Working Group and a Patient Working Group, (members of the Vitiligo International Patient Organizations Committee (VIPOC).
The meeting of the representatives of both the scientific and patient working groups with the new members of the European Parliament is an important step for all vitiligo patients. Not only in Europe but also globally. We hope that this White Paper will contribute to the recognition of vitiligo as an under-reported (non-communicable) disease that requires not only immediate attention but also action! Active collaboration with policy makers, healthcare professionals and patient organisations can significantly improve the lives of vitiligo patients and contribute to better care and better understanding.
This document is an important milestone with a lot of information and recommendations. It will serve as a reference framework for the interests of vitiligo patients in the coming years. We therefore strongly recommend that you bring this Vitiligo White Paper to the attention of your healthcare provider/practitioner when visiting them.
Paul A. Monteiro, Chairman Vitiligo.nl and Board Member Vitiligo International Patient Organizations Committee, VIPOC

